Ann: FDA approves Cochlear Nucleus Hybrid for sal, page-4

  1. 2,547 Posts.
    lightbulb Created with Sketch. 132
    re: Ann: FDA approves Cochlear Nucleus Hybrid... Here is an interesting comment from Motley Fool:

    Foolish takeaway

    Cochlear was the most-shorted individual stock on the ASX as at 14 March 2014, followed by News Corp (ASX: NWS), UGL Limited (ASX: UGL) and Monadelphous Group (ASX: MND). With Cochlear shares up 2.5% at lunchtime today, many of those shorters may well be forced to cover their positions in the days, weeks and months ahead. I certainly wouldn’t want to be standing in front of the Cochlear train at this point in time.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$317.54
Change
-1.885(0.59%)
Mkt cap ! $20.88B
Open High Low Value Volume
$316.74 $318.85 $316.74 $2.950M 9.292K

Buyers (Bids)

No. Vol. Price($)
3 9 $317.51
 

Sellers (Offers)

Price($) Vol. No.
$317.56 19 9
View Market Depth
Last trade - 10.40am 30/07/2025 (20 minute delay) ?
COH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.